Rami Komrokji
拉米·科姆罗基
MD
Vice Chair, Malignant Hematology Department恶性血液科副主任
👥Biography 个人简介
Vice Chair of Malignant Hematology at Moffitt Cancer Center, recognized internationally for MDS translational research. His work on splicing factor mutations, luspatercept, and risk stratification has directly advanced diagnostic and therapeutic standards for MDS worldwide.
🧪Research Fields 研究领域
🎓Key Contributions 主要贡献
Splicing Factor Mutations in MDS
Characterized the prognostic and therapeutic implications of SF3B1, SRSF2, and U2AF1 mutations in MDS, enabling mutation-informed treatment decisions and novel drug targeting strategies.
Luspatercept in MDS
Led key clinical investigation of luspatercept for anemia in MDS, contributing to Phase III evidence supporting FDA approval and establishing erythroid maturation agents as a new treatment class.
Representative Works 代表性著作
Luspatercept in patients with lower-risk myelodysplastic syndromes
New England Journal of Medicine (2020)
Phase III MEDALIST trial demonstrating luspatercept reduces transfusion burden in SF3B1-mutant MDS, supporting approval of the first erythroid maturation agent for MDS.
Splicing factor mutations in MDS: impact on prognosis and therapy
Leukemia (2019)
Comprehensive analysis linking splicing factor genotype to clinical outcomes and drug sensitivity, informing precision-based stratification and emerging targeted therapy trials.
🏆Awards & Recognition 奖项与荣誉
📄Data Sources 数据来源
Last updated: 2026-01-15 | All information from publicly available academic sources
Related Experts 相关专家
Elihu Estey
Fred Hutchinson Cancer Center
Hagop Kantarjian
The University of Texas MD Anderson Cancer Center
Naval Daver
The University of Texas MD Anderson Cancer Center
Courtney DiNardo
The University of Texas MD Anderson Cancer Center
关注 拉米·科姆罗基 的研究动态
Follow Rami Komrokji's research updates
留下邮箱，当我们发布与 Rami Komrokji（Moffitt Cancer Center）相关的新研究或访谈时，我们会通知你。
Explore More Experts
Discover the researchers shaping the future of cancer treatment